Oropharyngeal cancer
Jump to navigation
Jump to search
| Oropharyngeal cancer | |
|---|---|
| Term | Oropharyngeal cancer |
| Short definition | Orgovyx - (pronounced) (or-GOH-vix) A drug used to treat adults with advanced prostate cancer. Orgovyx attaches to gonadotropin-releasing hormone (GnRH) receptors in the pituitary gland, which stops the pituitary gland from making the hormones follicle-stimulating hormone (FSH) and luteinizing hormone (LH). |
| Type | Cancer terms |
| Specialty | Oncology |
| Language | English |
| Source | NCI |
| Comments | |
Oropharyngeal cancer - (pronounced) (OR-oh-fuh-RIN-jee-ul-KAN-ser) Cancer that forms in the tissues of the oropharynx (the part of the throat at the back of the mouth, including the soft palate, base of the tongue and tonsils). Most oropharyngeal cancers are squamous cell carcinomas (cancer that begins in flat cells lining the oropharynx)
External links
- Medical encyclopedia article on Oropharyngeal cancer
- Wikipedia's article - Oropharyngeal cancer
This WikiMD article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski